First detection of triazole‐resistant aspergillus fumigatus harbouring the TR34/L98H Cyp51A mutation in Burkina Faso

Abstract

AbstractBackgroundTriazole‐resistant Aspergillus fumigatus (TRAF) isolates are a growing public health problem with worldwide distribution. Epidemiological data on TRAF is limited in Africa, particularly in West Africa.ObjectivesThis study aimed to screen for the environmental presence of TRAF isolates in the indoor air of two hospitals in Burkina Faso.Materials and MethodsAir samples were collected in wards housing patients at risk for invasive aspergillosis, namely infectious diseases ward, internal medicine ward, nephrology ward, pulmonology ward, medical emergency ward and paediatric ward. Sabouraud Dextrose Agar supplemented with triazoles was used to screen the suspected TRAF isolates and EUCAST method to confirm the resistance of suspected isolates. Sequencing of cyp51A gene was used to identify the resistance mechanism of confirmed TRAF isolates.ResultsOf the 198 samples collected and analysed, 67 showed growth of A. fumigatus isolates. The prevalence of TRAF isolates was 3.23% (4/124). One TRAF isolate exhibited a pan‐triazole resistance. Sequencing of cyp51A gene identified the TR34/L98H mutation for this pan‐triazole resistant isolate. This study showed for the first time the circulation of the pan‐azole resistant isolate harbouring the TR34/L98H mutation in Burkina Faso.ConclusionsThese findings emphasise the need to map these TRAF isolates in all parts of Burkina Faso and to establish local and national continuous surveillance of environmental and clinical TRAF isolates in this country.